Residency Award

Sponsored by Pfizer Canada


About the Award


The Pharmacy Practice Residency Award recognizes year 1 pharmacy practice residents whose major projects are judged to be most deserving in terms of significant innovation, practical application, and/or development in an institutional pharmacy practice setting. Winners receive a $1000 cash prize.

Award Criteria

To be eligible, each candidate must:

  • Be a current member of CSHP and must have been a Member of CSHP at the time the residency was completed;
  • Be currently enrolled in, or one year post-completion, of a CPRB-accredited (or accreditation-pending) year 1 pharmacy practice residency program in the province of the branch administering the award. For the 2022 award, Members from the 2020-2021 and 2021-2022 residency programs are eligible, depending on the submission deadline set by the branch; and
  • Submit an award application to the branch in the province in which the residency was completed. The residency project manuscript must be formatted according to the Canadian Journal of Hospital Pharmacy's (CJHP) Author Guidelines.

Winners of the 2021 award may not apply for the 2022 award.

Application Process

Each branch will be entitled to one Pharmacy Practice Residency Award for every 10 pharmacy residents who are CSHP Members and who are enrolled in a CPRB-accredited (or accreditation-pending) program in the province. All participating branches advertise and administer the program annually within their respective branches. The branches also adjudicate the award submissions and present the awards at branch award presentations.

Check your branch website for submission requirements and deadlines.

    Winners of the 2021 Pharmacy Practice Residency Award, sponsored by Pfizer Canada



    British Columbia Branch (4 awards)


    1. Caitlin Gordon (Lower Mainland Pharmacy Services)
    • Effectiveness of Very Low Dose Alprostadil for Achieving Ductal Patency (CIRCULATE)
    2. Jamil Devsi (Lower Mainland Pharmacy Services)
    • Describing Intravenous Extravasation Injuries in Children (DIVE2 Study) 
    3. Kate McDougal (Lower Mainland Pharmacy Services)
    • Development, Implementation, and Evaluation of Vancomycin AUC/MIC Therapeutic Drug Monitoring 
    4. Shelby McGraw (Northern Health)
    • Primary care pharmacists’ perceived confidence and efficacy in managing patients with suicidal ideation – An assessment of a pilot educational module

    Alberta Branch (1 award)

    5. Jordan Kelly (Alberta Health Services)
    • Current UTI Antibiotic Prescribing Practices in a Pediatric Emergency Department: Is it a problem worth Cefix-ing?

    Saskatchewan Branch (1 award)

    6. Caitlin Dempsey (Saskatchewan Health Authority, Regina Area)
    • Assessment and Prevention of Burnout in Canadian Pharmacy Residency Programs

    Manitoba Branch (1 award)

    7. Deanna Flaten (Winnipeg Regional Health Authority)
    • Risk of Prosthetic Joint Infection Treatment Failure: A Retrospective Chart Review in an Outpatient Intravenous Program

    New Brunswick and Nova Scotia Branches (1 award)

    8. Erin Ring (IWK)
    • Evaluating Barriers and Facilitators to Delivery of Hospital Pharmacy Services to Women, Children, and their Families During a Pandemic

    Newfoundland and Labrador Branch (1 award)

    9. Rebecca Norman (Eastern Health)
    • The use of Aspirin for Thromboprophylaxis Compared to Alternative Anticoagulants in Elective Total Hip Replacement: A Retrospective Cohort Study

    Ontario Branch (4 awards)

    10. Danielle Porter (Sunnybrook Health Sciences Centre)
    • Evaluating the Influence of Intravenous Ketamine on Post-operative Opioid Use in Surgical Patients at a Tertiary Care Centre
    11. Marie-Claire Savoie (The Ottawa Hospital/Montfort Hôpital)
    • Incidence and potential harm of medication discrepancies upon inter-facility patient transfer
    12. Giovanni Iovino (Windsor Regional Hospital)
    • The Impact of Decreasing Antibiotic Treatment Duration to Five Days for Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) and Community-Acquired Pneumonia (CAP)
    13. Hatf Sohail (Trillium Health Partners)
    • Raising the Bar: Impact of increased colony-count threshold on rates of antimicrobial prescribing for asymptomatic bacteriuria/candiduria in hospitalized patients
     

    2019 Award Recipients

    British Columbia Branch

    Mattie Bakker

    Lower Mainland Pharmacy Services

    A pharmacokinetic assessment of extended-interval aminoglycoside dosing in neonates
    Andrea Feere

    Lower Mainland Pharmacy Services

    Evaluation of venous thromboembolism prophylaxis in patients with moderate to severe traumatic brain injury
    Julia Ho

    Lower Mainland Pharmacy Services

    Safety of non-steroidal anti-inflammatory drugs in extremely low birth weight infants: a retrospective cohort study
    Brittney Mathers

    BC Cancer

    Use, response and outcomes of second line chemotherapy in patients with advanced biliary tract cancers


      Alberta Branch

      Thomas Brownlee

      Alberta Health Services, Calgary Zone

      Patient Factors Associated with Intravenous Iron Prescribing (INFeRX): A Descriptive Study


      Saskatchewan Branch

      Janelle Kraft

      Saskatchewan Health Authority, Saskatoon Integrated Service Area

      Implementation of Pharmacy Services to Identify and Evaluate Processes for Improving Admission Medication Reconciliation in a Pre-Assessment Clinic

      Manitoba Branch

      Katarina Popovic

      Winnipeg Regional Health Authority

      Pharmacist-Initiated Intravenous to Oral Antimicrobial Therapy Conversions in Adult Inpatients

      Ontario Branch

      Joseph Blommesteyn

      Unity Health Toronto

      Opioid Prescribing at Discharge for General Surgery Patients: A Prospective Study
      Samantha Polito

      University Health Network – General Program

      Evaluation of a Patient Self Medication Program in Allogeneic Hematopoietic Stem Cell Transplantation
      Elsa Purivatra

      Windsor Regional Hospital

      A Quality Assurance Evaluation of Hydromorphone Adverse Events Post-Implementation of a Safety Initiative
      Jessica Ragazzo

      University Health Network – General Program

      Development and Validation of a Uremic Pruritus Treatment Algorithm in Patients with Chronic Kidney Disease (CKD) and End Stage Kidney Disease (ESKD)

      New Brunswick & Nova Scotia Branches

      Krysta Spencer

      Nova Scotia Health Authority, Central Zone

      Roles and Perceptions of Pharmacists as Immunizers of Adult Patients in Tertiary Care Academic Hospitals: An Environmental Scan of Canadian Hospital Pharmacists

        Newfoundland and Labrador Branch

        Heather Williams

        Eastern Integrated Regional Health Authority

        Evaluating the necessity of ciprofloxacin use in hospitalized patients and the impact of a prospective targeted antimicrobial intervention